标题
Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer
作者
关键词
-
出版物
eLife
Volume 10, Issue -, Pages -
出版商
eLife Sciences Publications, Ltd
发表日期
2021-04-23
DOI
10.7554/elife.55070
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas
- (2021) Yiyun Sun et al. Genes
- Pan-Cancer Analysis of Head-to-Head Gene Pairs in Terms of Transcriptional Activity, Co-expression and Regulation
- (2021) Yunqin Chen et al. Frontiers in Genetics
- Identification of a Five-Gene Prognostic Model and Its Potential Drug Repurposing in Colorectal Cancer Based on TCGA, GTEx and GEO Databases
- (2021) Feng Yang et al. Frontiers in Genetics
- MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivity
- (2021) Timothy B. Branigan et al. Cell Reports
- FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex Vivo
- (2021) Luzie Brückner et al. Cancers
- FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
- (2021) Dhanya Kalathil et al. Frontiers in Oncology
- EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition
- (2020) Sergey Karakashev et al. CANCER CELL
- Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells
- (2020) Brian T. Burgess et al. Diagnostics
- Fanconi Anemia Pathway Activation by FOXM1 Is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance
- (2020) Yun-Gil Roh et al. Cancers
- DNA Replication Stress and Chromosomal Instability: Dangerous Liaisons
- (2020) Therese Wilhelm et al. Genes
- Peritoneal Spread of Ovarian Cancer harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling
- (2020) Deepak Parashar et al. CANCER RESEARCH
- FOXM1 drives HPV+ HNSCC sensitivity to WEE1 inhibition
- (2020) Ahmed Diab et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Replication stress and FOXM1 drive radiation induced genomic instability and cell transformation
- (2020) Zhentian Li et al. PLoS One
- Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer
- (2019) Carter Barger et al. Cancers
- FOXM1 Deubiquitination by USP21 Regulates Cell Cycle Progression and Paclitaxel Sensitivity in Basal-like Breast Cancer
- (2019) Anthony Arceci et al. Cell Reports
- Freeware tool for analysing numbers and sizes of cell colonies
- (2019) Beata Brzozowska et al. RADIATION AND ENVIRONMENTAL BIOPHYSICS
- Exploiting DNA Replication Stress for Cancer Treatment
- (2019) Tajinder Ubhi et al. CANCER RESEARCH
- Characterization of bidirectional gene pairs in The Cancer Genome Atlas (TCGA) dataset
- (2019) Juchuanli Tu et al. PeerJ
- PLAGL2 and POFUT1 are regulated by an evolutionarily conserved bidirectional promoter and are collaboratively involved in colorectal cancer by maintaining stemness
- (2019) Daojiang Li et al. EBioMedicine
- A Structure-Activity Relationship Study of Forkhead Domain Inhibitors (FDI): the importance of halogen binding interactions
- (2019) Seyed Amirhossein Tabatabaei Dakhili et al. BIOORGANIC CHEMISTRY
- Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma
- (2019) Jing Song et al. Aging-US
- Silencing of FoxM1 blocks growth, migration and invasion of papillary thyroid carcinoma cells
- (2019) Xiaotao Wang et al. Oncology Letters
- Olaparib-induced Adaptive Response Is Disrupted by FOXM1 Targeting that Enhances Sensitivity to PARP Inhibition
- (2018) Pingping Fang et al. MOLECULAR CANCER RESEARCH
- Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer
- (2018) Huafeng Pan et al. World Journal of Surgical Oncology
- An accurate and robust imputation method scImpute for single-cell RNA-seq data
- (2018) Wei Vivian Li et al. Nature Communications
- FoxM1 repression during human aging leads to mitotic decline and aneuploidy-driven full senescence
- (2018) Joana Catarina Macedo et al. Nature Communications
- Pan-Cancer Analysis Reveals Differential Susceptibility of Bidirectional Gene Promoters to DNA Methylation, Somatic Mutations, and Copy Number Alterations
- (2018) Jeffrey Thompson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An intrinsic S/G2 checkpoint enforced by ATR
- (2018) Joshua C. Saldivar et al. SCIENCE
- Coordinately targeting cell cycle checkpoint functions in integrated models of pancreatic cancer
- (2018) Sejin Chung et al. CLINICAL CANCER RESEARCH
- CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1
- (2018) Longxi Mao et al. EXPERIMENTAL CELL RESEARCH
- The fallopian tube, “precursor escape” and narrowing the knowledge gap to the origins of high-grade serous carcinoma
- (2018) Thing Rinda Soong et al. GYNECOLOGIC ONCOLOGY
- Expression of the POTE gene family in human ovarian cancer
- (2018) Carter J Barger et al. Scientific Reports
- FoxM1 Promotes Cell Proliferation, Invasion, and Stem Cell Properties in Nasopharyngeal Carcinoma
- (2018) Weiren Luo et al. Frontiers in Oncology
- ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells
- (2017) Stephanie A. Yazinski et al. GENES & DEVELOPMENT
- Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells
- (2017) Boris J. Winterhoff et al. GYNECOLOGIC ONCOLOGY
- PARP inhibitors: Clinical utility and possibilities of overcoming resistance
- (2017) Benjamin G. Bitler et al. GYNECOLOGIC ONCOLOGY
- FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
- (2017) Renata A. Tassi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A single-cell survey of the small intestinal epithelium
- (2017) Adam L. Haber et al. NATURE
- Toil enables reproducible, open source, big biomedical data analyses
- (2017) John Vivian et al. NATURE BIOTECHNOLOGY
- The control of DNA repair by the cell cycle
- (2017) Nicole Hustedt et al. NATURE CELL BIOLOGY
- Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
- (2017) Julia Joung et al. Nature Protocols
- Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis
- (2017) Lijun Li et al. Oncotarget
- Transcriptional landscape of human cancers
- (2017) Mengyuan Li et al. Oncotarget
- Suppression of FOXM1 Transcriptional Activities via a Single-Stranded DNA Aptamer Generated by SELEX
- (2017) Qin Xiang et al. Scientific Reports
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- FOXM1 participates in PLK1-regulated cell cycle progression in renal cell cancer cells
- (2016) ZHE ZHANG et al. Oncology Letters
- The presence of extra chromosomes leads to genomic instability
- (2016) Verena Passerini et al. Nature Communications
- Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
- (2016) A. J. Aguirre et al. Cancer Discovery
- Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease
- (2016) James Haley et al. Oncotarget
- FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells
- (2016) Uday B. Maachani et al. Oncotarget
- Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
- (2015) Christopher J. Lord et al. Annual Review of Medicine
- The gene pair PRR11 and SKA2 shares a NF-Y-regulated bidirectional promoter and contributes to lung cancer development
- (2015) Yitao Wang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Different distribution of histone modifications in genes with unidirectional and bidirectional transcription and a role of CTCF and cohesin in directing transcription
- (2015) Susanne Bornelöv et al. BMC GENOMICS
- RHINO forms a stoichiometric complex with the 9-1-1 checkpoint clamp and mediates ATR-Chk1 signaling
- (2015) Laura A Lindsey-Boltz et al. CELL CYCLE
- FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance
- (2015) Gabriela Nestal de Moraes et al. CELLULAR SIGNALLING
- FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
- (2015) G. Kim et al. CLINICAL CANCER RESEARCH
- Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review
- (2015) Jun Dai et al. DISEASE MARKERS
- Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase
- (2015) Rémi Buisson et al. MOLECULAR CELL
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements
- (2015) Pratiksha I Thakore et al. NATURE METHODS
- Inference of transcriptional regulation in cancers
- (2015) Peng Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer
- (2015) Qipeng Fan et al. Oncotarget
- Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression
- (2015) Carter J Barger et al. Oncotarget
- Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells
- (2015) Xuan Zhang et al. Oncotarget
- FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance
- (2014) Stefania Zona et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- The PRKCI and SOX2 Oncogenes Are Coamplified and Cooperate to Activate Hedgehog Signaling in Lung Squamous Cell Carcinoma
- (2014) Verline Justilien et al. CANCER CELL
- An update on PARP inhibitors—moving to the adjuvant setting
- (2014) Amir Sonnenblick et al. Nature Reviews Clinical Oncology
- Easy quantitative assessment of genome editing by sequence trace decomposition
- (2014) Eva K. Brinkman et al. NUCLEIC ACIDS RESEARCH
- Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance
- (2014) Fung Zhao et al. PLoS One
- Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition
- (2014) Michael V. Gormally et al. Nature Communications
- Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube-Derived High-Grade Serous Ovarian Cancers
- (2013) A. M. Karst et al. CANCER RESEARCH
- ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status
- (2013) C. J. Huntoon et al. CANCER RESEARCH
- LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients
- (2013) Stacey N. Akers et al. GYNECOLOGIC ONCOLOGY
- FOX(M1) News--It Is Cancer
- (2013) M. Halasi et al. MOLECULAR CANCER THERAPEUTICS
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance
- (2013) P Khongkow et al. ONCOGENE
- FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis
- (2013) K Levanon et al. ONCOGENE
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Mechanisms of Resistance to PARP Inhibitors—Three and Counting
- (2013) Tito Fojo et al. Cancer Discovery
- Targeting FOXM1 in cancer
- (2012) Marianna Halasi et al. BIOCHEMICAL PHARMACOLOGY
- The dual lives of bidirectional promoters
- (2012) Clay Wakano et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction
- (2012) Jian Ye et al. BMC BIOINFORMATICS
- FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair
- (2012) Yun-Yong Park et al. CARCINOGENESIS
- FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients
- (2012) Yu Wang et al. LUNG CANCER
- The Forkhead Transcription Factor FOXM1 Controls Cell Cycle-Dependent Gene Expression through an Atypical Chromatin Binding Mechanism
- (2012) X. Chen et al. MOLECULAR AND CELLULAR BIOLOGY
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment
- (2012) L J Monteiro et al. ONCOGENE
- Correct End Use during End Joining of Multiple Chromosomal Double Strand Breaks Is Influenced by Repair Protein RAD50, DNA-dependent Protein Kinase DNA-PKcs, and Transcription Context
- (2011) Amanda Gunn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
- (2011) A. M. Karst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A DNA Damage Response Screen Identifies RHINO, a 9-1-1 and TopBP1 Interacting Protein Required for ATR Signaling
- (2011) C. Cotta-Ramusino et al. SCIENCE
- Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin
- (2010) Vladimir Petrovic et al. CANCER BIOLOGY & THERAPY
- FoxM1 Mediates Resistance to Herceptin and Paclitaxel
- (2010) Janai R. Carr et al. CANCER RESEARCH
- Two-fold elevation of expression of FoxM1 transcription factor in mouse embryonic fibroblasts enhances cell cycle checkpoint activity by stimulating p21 and Chk1 transcription
- (2010) Y. Tan et al. CELL PROLIFERATION
- Involvement of C12orf32 overexpression in breast carcinogenesis
- (2010) Nakamura INTERNATIONAL JOURNAL OF ONCOLOGY
- FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
- (2010) J. M.-M. Kwok et al. MOLECULAR CANCER RESEARCH
- FoxM1, a Forkhead Transcription Factor Is a Master Cell Cycle Regulator for Mouse Mature T Cells but Not Double Positive Thymocytes
- (2010) Ling Xue et al. PLoS One
- Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer
- (2008) A. Woloszynska-Read et al. CLINICAL CANCER RESEARCH
- FoxM1 inhibitors as potential anticancer drugs
- (2008) Andrei L Gartel EXPERT OPINION ON THERAPEUTIC TARGETS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started